Effects of Intratumoral Injection of CCL2 on Monocyte–Endothelial Cell Interactions in Mouse Pancreatic Cancer

REFERENCES

• Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H, Tominaga S. Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol 2003; 32: 257–262
   PubMed Web of Science ®Google Scholar
• Lin Y, Tamakoshi A, Wakai K, Kawamura T, Aoki R, Kojima M, Ohno Y. Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 1998; 8: 52–59
   Google Scholar
• Xiong H Q, Abbruzzese J L, Esumi H, Kosuge T, Kakizoe T, Sugimura T. Report of the 16th International Symposium of the Foundation for Promotion of Cancer Research: recent advances in pancreatic cancer. Jpn J Clin Oncol 2003; 33: 246–253
   Google Scholar
• Balch C M, Riley L B, Bae Y J, Salmeron M A, Platsoucas C D, von Eschenbach A, Itoh K. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990; 125: 200–205
   PubMed Web of Science ®Google Scholar
• Evans R. Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice. Int J Cancer 1980; 26: 227–229
   Google Scholar
• Gauci C L, Alexander P. The macrophage content of some human tumours. Cancer Lett 1975; 1: 29–32
   PubMed Web of Science ®Google Scholar
• Rowland F N, Donovan M J, Lindsay M, Weiss W I, O'Rourke J, Kreutzer D L. Demonstration of inflammatory mediator-induced inflammation and endothelial cell damage in the anterior segment of the eye. Am J Pathol 1983; 110: 1–12
   PubMed Web of Science ®Google Scholar
• Miller M D, Krangel M S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12: 17–46
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S, Lipton B A, Rosenfeld M E, Sarkioja T, Yoshimura T, Leonard E J, Witztum J L, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991; 88: 5252–5256
   PubMed Web of Science ®Google Scholar
• Fuentes M E, Durham S K, Swerdel M R, Lewin A C, Barton D S, Megill J R, Bravo R, Lira S A. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995; 155: 5769–5776
   PubMed Web of Science ®Google Scholar
• Rutledge B J, Rayburn H, Rosenberg R, North R J, Gladue R P, Corless C L, Rollins B J. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995; 155: 4838–4843
   PubMed Web of Science ®Google Scholar
• Gunn M D, Nelken N A, Liao X, Williams L T. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 1997; 158: 376–383
   PubMed Web of Science ®Google Scholar
• Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 1995; 25: 64–68
   PubMed Web of Science ®Google Scholar
• Zhang L, Khayat A, Cheng H, Graves D T. The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth. Lab Invest 1997; 76: 579–590
   PubMed Web of Science ®Google Scholar
• Boring L, Gosling J, Chensue S W, Kunkel S L, Farese R V, Jr, Broxmeyer H E, Charo I F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552–2561
   PubMed Web of Science ®Google Scholar
• Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997; 186: 1757–1762
   PubMed Web of Science ®Google Scholar
• Kuziel W A, Morgan S J, Dawson T C, Griffin S, Smithies O, Ley K, Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 1997; 94: 12053–12058
   PubMed Web of Science ®Google Scholar
• Conti I, Rollins B J. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004; 14: 149–154
   PubMed Web of Science ®Google Scholar
• Piessens W F, Churchill W H, David J R. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells. J Immunol 1975; 114: 293–299
   Google Scholar
• Wang B S, Lumanglas A L, Durr F E. Immunotherapy of a murine lymphoma by adoptive transfer of syngeneic macrophages activated with bisantrene. Cancer Res 1986; 46: 503–506
   PubMed Web of Science ®Google Scholar
• Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265–270
   PubMedGoogle Scholar
• van Netten J P, Ashmead B J, Parker R L, Thornton I G, Fletcher C, Cavers D, Coy P, Brigden M L. Macrophage-tumor cell associations: a factor in metastasis of breast cancer?. J Leukoc Biol 1993; 54: 360–362
   Google Scholar
• van Ravenswaay Claasen H H, Kluin P M, Fleuren G J. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest 1992; 67: 166–174
   PubMed Web of Science ®Google Scholar
• Ishii N, Tsuzuki Y, Matsuzaki K, Miyazaki J, Okada Y, Hokari R, Kawaguchi A, Nagao S, Itoh K, Miura S. Endotoxin stimulates monocyte–endothelial cell interactions in mouse intestinal Peyer's patches and villus mucosa. Clin Exp Immunol 2004; 135: 226–232
   Google Scholar
• Inoue T, Tsuzuki Y, Matsuzaki K, Matsunaga H, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K, Matsumoto S, Miura S. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J Leukoc Biol 2004; 77: 287–295
   Google Scholar
• Dirkx A E, Oude Egbrink M G, Kuijpers M J, van der Niet S T, Heijnen V V, Bouma-ter Steege J C, Wagstaff J, Griffioen A W. Tumor angiogenesis modulates leukocyte–vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003; 63: 2322–2329
   PubMed Web of Science ®Google Scholar
• Miyazaki J, Tsuzuki Y, Matsuzaki K, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K, Miura S. Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer. Int J Cancer 2005; 117: 499–505
   PubMedGoogle Scholar
• Brown N J, Ali S, Reed M W, Wiltrout R, Rees R C. Trafficking of activated lymphocytes into the RENCA tumour microcirculation in vivo in mice. Br J Cancer 1997; 76: 1572–1578
   Google Scholar
• Peeters C F, Ruers T J, Westphal J R, de Waal R M. Progressive loss of endothelial P-selectin expression with increasing malignancy in colorectal cancer. Lab Invest 2005; 85: 248–256
   PubMed Web of Science ®Google Scholar
• Forster-Horvath C, Dome B, Paku S, Ladanyi A, Somlai B, Jalkanen S, Timar J. Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma. Melanoma Res 2004; 14: 135–140
   Google Scholar
• Tsuzuki Y., Mouta Carreira C, Bockhorn M, Xu L, Jain R K, Fukumura D. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 2001; 81: 1439–1451
   PubMed Web of Science ®Google Scholar
• Boucher Y, Lee I, Jain R K. Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors. Microvasc Res 1995; 50: 175–182
   PubMed Web of Science ®Google Scholar
• Walter S, Bottazzi B, Govoni D, Colotta F, Mantovani A. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int J Cancer 1991; 49: 431–435
   Google Scholar
• Heldin C H, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure—an obstacle in cancer therapy. Nat Rev Cancer 2004; 4: 806–813
   PubMed Web of Science ®Google Scholar
• Dvorak H F, Brown L F, Detmar M, Dvorak A M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–1039
   PubMed Web of Science ®Google Scholar
• Padera T P, Stoll B R, Tooredman J B, Capen D, di Tomaso E, Jain R K. Pathology: cancer cells compress intratumour vessels. Nature 2004; 427: 695
   PubMed Web of Science ®Google Scholar
• Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002; 1: 219–227
   PubMed Web of Science ®Google Scholar
• Leu A J, Berk D A, Lymboussaki A, Alitalo K, Jain R K. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 2000; 60: 4324–4327
   PubMed Web of Science ®Google Scholar
• Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004; 4: 360–370
   PubMed Web of Science ®Google Scholar
• Weber C, Belge K U, von Hundelshausen P, Draude G, Steppich B, Mack M, Frankenberger M, Weber K S, Ziegler-Heitbrock H W. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000; 67: 699–704
   PubMed Web of Science ®Google Scholar
• Haringman J J, Smeets T J, Reinders-Blankert P, Tak P P. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of rheumatoid arthritis, osteoarthritis and reactive arthritis patients. Ann Rheum Dis 2006; 65: 294–300
   PubMed Web of Science ®Google Scholar